Related Experiment Video
Updated: Jun 3, 2026
A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Bioanalytical determination of unstable endogenous small peptides: RFRP3 and its metabolites in rat blood
Julian J Haynes1, Hannah Jones, Drew Gibson
1Department of Pharmacokinetics, Dynamics and Metabolism (PDM), PGRD, Sandwich Laboratories, Kent, UK. Julian.haynes2@pfizer.com
Background:
Targeting the gonadotropin-releasing hormone pathway for the treatment of endometriosis leads to an interest in monitoring for endogenous modulators of this pathway (RFRP3 and kisspeptin) as baseline controls for treatment development.
Results:
Stabilization of RFRP3 was shown to be extremely difficult in a highly enzymatically active matrix, such as rat blood. Sample denaturing with solvent at collection was necessary due to enzyme inhibition being unsuccessful at stabilization leading to difficulties in sample processing. Monitoring multiple fragments formed in blood can aid in profiling these peptides once in-source conversion is controlled.
Conclusion:
generic high-sensitivity LC-MS/MS assay was developed for RFRP3 and the fragments formed from it in whole blood. Use of 2D chromatography circumvents concentration and retention issues related to small fragments with a normal flow setup, making a more open-access approach feasible.
Insights
Developing a sensitive assay for RFRP3 peptide in blood is challenging due to enzymatic degradation. This study presents a novel LC-MS/MS method to accurately measure RFRP3 and its fragments in whole blood samples.
Area of Science:
- Endocrinology
- Analytical Chemistry
- Peptide Assays
Background:
- Endometriosis treatment targets the gonadotropin-releasing hormone pathway.
- Monitoring endogenous modulators like RFRP3 and kisspeptin is crucial for treatment development.
- RFRP3 stability in biological matrices presents significant analytical challenges.
Purpose of the Study:
- To develop a high-sensitivity assay for quantifying RFRP3 and its fragments in whole blood.
- To address challenges in peptide stabilization and detection in an enzymatically active environment.
Main Methods:
- Development of a generic, high-sensitivity liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay.
- Utilized 2D chromatography to overcome concentration and retention issues with small peptide fragments.
- Employed sample denaturing with solvent at collection to manage enzymatic degradation.
Main Results:
- Successfully developed and validated an LC-MS/MS assay for RFRP3 and its blood-formed fragments.
- Demonstrated the necessity of immediate sample denaturing due to high enzymatic activity in rat blood.
- Showcased the utility of monitoring multiple fragments for comprehensive peptide profiling.
Conclusions:
- A robust LC-MS/MS assay enables accurate measurement of RFRP3 and its degradation products in whole blood.
- 2D chromatography is effective in resolving challenges associated with small peptide fragment analysis.
- This method provides a feasible, open-access approach for monitoring RFRP3 in biological samples.
